Investing.com -- Recursion Pharmaceuticals (NASDAQ:RXRX) stock rose 7% Monday following positive Phase 2 trial results for its experimental drug REC-4881 in familial adenomatous polyposis (FAP), a ...

It has been about a month since the last earnings report for Recursion Pharmaceuticals (RXRX). Shares have added about 6.5% in that time frame, outperforming the S&P 500. But investors have to be ...

Partying the night before a big exam. Preparing last-minute for a work presentation. Running a 5K in a 10-pound Halloween ...

Spartacus: House of Ashur,” premiering this month on Starz, brings the cult favorite 2010s action series back in an unlikely ...

Recordati Rare Diseases Inc. today announced the presentation of new data detailing advances in the understanding of Castleman disease (CD), a group of rare immune system disorders characterized by ...

Cathie Wood’s ARK Invest executed a busy week of portfolio adjustments across its ETFs, with several high-conviction ...

Threat intel gets useful when you stop chasing feeds and start mapping flows — ULM shows how attacks actually move, so CISOs ...

On the buying side, ARK significantly increased its position in Coinbase Global Inc (NASDAQ:COIN), purchasing 28,315 shares through its ARKK ETF, with a total value of $7,357,369. This follows a ...

From analog hobbies to tech curfews, these Gen Zers are experimenting with science-backed ways to help their brains feel a little less foggy.

Environmental Engel curves characterize the relationship between the embodied environmental impact of household consumption ...

Paste Magazine is your source for the best music, movies, TV, comedy, videogames, books, comics, craft beer, politics and ...

HBO's 90% RT financial thriller Industry, which has a stand-out performance by Kit Harington, is an addictive binge for ...